Library / Research areas / Weight & metabolism
Weight & metabolism
GLP-1 medicines, metabolic hormones and research peptides studied for body weight, appetite and blood sugar.
These compounds are grouped by what they are studied for. Being studied for something is not the same as being proven to work, or safe. Compounds are listed from the strongest human evidence to the weakest.
Approved use · Regulator-approved for a specific indication
Insulin (human)
Metabolic Research
51residues
5,794daltons
Evidence: Approved use
Insulin aspart
Metabolic Research
51residues
5,832daltons
Evidence: Approved use
Insulin degludec
Metabolic Research
51residues
6,104daltons
Evidence: Approved use
Insulin detemir
Metabolic Research
51residues
5,917daltons
Evidence: Approved use
Insulin glargine
Metabolic Research
53residues
6,063daltons
Evidence: Approved use
Insulin glulisine
Metabolic Research
51residues
5,823daltons
Evidence: Approved use
Insulin lispro
Metabolic Research
51residues
5,814daltons
Evidence: Approved use
Linaclotide
Metabolic Research
14residues
1,527daltons
Evidence: Approved use
Lixisenatide
Metabolic Research
44residues
4,858daltons
Evidence: Approved use
Plecanatide
Metabolic Research
16residues
1,682daltons
Evidence: Approved use
Secretin
Metabolic Research
27residues
3,056daltons
Evidence: Approved use
Teduglutide
Metabolic Research
34residues
3,752daltons
Evidence: Approved use
Dulaglutide
Metabolic Research
Largeprotein
63,000daltons
Evidence: Approved use
Exenatide
Metabolic Research
39residues
4,186.6daltons
Evidence: Approved use
Glucagon
Metabolic Research
29residues
3,482.8daltons
Evidence: Approved use
Liraglutide
Metabolic Research
31residues
3,751.2daltons
Evidence: Approved use
Pramlintide
Metabolic Research
37residues
3,949.4daltons
Evidence: Approved use
Semaglutide
Metabolic Research
31residues
4,113.6daltons
Evidence: Approved use
Tesamorelin
Endocrine & Growth
44residues
5,135.9daltons
Evidence: Approved use
Tirzepatide
Metabolic Research
39residues
4,813.5daltons
Evidence: Approved use
Controlled trials · Randomized trials with clinical endpoints
CBL-514
Related Molecules · Not a peptide
Caliway’s investigational small molecule for localized fat reduction.
Small moleculeClassification
Phase 3Abdominal fat program
Evidence: Controlled trials
Albiglutide
Metabolic Research
—residues
72,000daltons
Evidence: Controlled trials
Cagrilintide
Metabolic Research
38residues
4,409daltons
Evidence: Controlled trials
AOD-9604
Metabolic Research
16residues
1,815daltons
Evidence: Controlled trials
Retatrutide
Metabolic Research
39residues
4,731.4daltons
Evidence: Controlled trials
Early human · Small pharmacology or safety studies in people
Preclinical · Cell and animal studies only
MOTS-c
Mitochondrial & Longevity
16residues
2,174.6daltons
Evidence: Preclinical
Neuropeptide Y
Neuroscience
36residues
4,271.7daltons
Evidence: Preclinical
Other research areas
Energy & mitochondriaSleepRecovery & repairGrowth hormoneBrain & moodImmunitySkin & hairLongevity & agingSexual & reproductive healthHormones & boneHeart & blood
Educational reference only. Nothing here is medical advice, a treatment recommendation, or dosing or sourcing guidance.